Crystallization Features of the Chiral Drug Timolol Precursor: The Rare Case of Conglomerate with Partial Solid Solutions
A synthetic precursor of the chiral drug timolol, 4-[4-(oxiran-2-ylmethoxy)-1,2,5-thiadiazol-3-yl]-morpholine (2) represents a rare case of conglomerate with partial solid solution. This fact was established by inspection of an original solubility test, by the originally developed IR spectra analysi...
Saved in:
Published in | Crystal growth & design Vol. 14; no. 4; pp. 1676 - 1683 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English Russian |
Published |
Washington,DC
American Chemical Society
02.04.2014
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!